InvestorsHub Logo
Followers 148
Posts 9077
Boards Moderated 0
Alias Born 05/17/2005

Re: None

Saturday, 11/16/2013 8:18:11 PM

Saturday, November 16, 2013 8:18:11 PM

Post# of 54998
Would appreciate hearing what other investors feel are the current risks regarding our investment with XXII.

I can only come up with the following:

BAT terminating the collaboration but after 2 years of them analyzing our technology that seems unlikely IMO.

The govt could reject our application for entry into the MSA but again that seems mighty unlikely since someone posted Goodrich passed the inspection by the TTB and our license was suppose to be forthcoming in 60-90 days.

Govt could reject the acquisition of NASCO but it was so small can't see why they would do that. Again, if this is done and the Goodrich application fails we would be locked out of the US market and I am not sure we could even produce cigarettes here strictly for export. Having both NASCO acquisition and Goodrich MSA application rejected seems extremely unlikely.

We could be locked out of worldwide distribution of product such but that seems far fetched as we already have a foothold in Benelux.

Govt could terminate the X22 trial but after 2 years of study I think they already know how that trial is going to turn out (out that should be completely in XXII's favor).

The above all occurring could put XXII in quite a squeeze but the likelihood of it coming to pass seems to me about negligible.

Bottom line: #$*% happens but for XXII I believe the risks seem extremely minimal. May take a year or two for stock price to really rise (worst case scenario) but I can't see how the company could have the bottom drop out of it at this stage of the game.

Hope I am not overlooking some obvious possible problem and will be surprised if someone comes up with a major red flag.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent XXII News